EICHOR
● Active Not Recruiting
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
Condition: Atrial Fibrillation · Sponsor: Boston Scientific Corporation
About this study
The goal of any novel design or therapeutic strategy to treat atrial fibrillation is to restore normal sinus rhythm and to reduce or eliminate the symptoms due to rapid atrial response. Boston Scientific has developed the FARAPULSE™ Pulsed Field Ablation therapy that uses irreversible electroporation to induce cell death. This Registry is intended to obtain purely observational and prospective real world data and to provide continued evidence on the safety and effectiveness when the FARAPULSE™ pulsed field ablation System is used per hospitals' standard of care.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (48)
| Prince Charles Hospital | Brisbane, Australia | — |
| Fiona Stanley Hospital | Murdoch, Australia | — |
| John Hunter Hospital | Newcastle, Australia | — |
| Allgemeines Krankenhaus AKH | Vienna, Austria | — |
| AZ Sint Jan Hospital | Bruges, Belgium | — |
| Hartcentrum Hasselt Jessa Ziekenhuis Campus Virga Jesse | Hasselt, Belgium | — |
| CHR de la Citadelle | Liège, Belgium | — |
| Neuron Medical in Brno | Brno, Czechia | — |
| Nemocnice Ceske Budejovice a.s. | České Budějovice, Czechia | — |
| Tays Heart Hospital | Tampere, Finland | — |
| CHU Grenoble | Grenoble, France | — |
| Hopital Saint Philibert-Hospital | Lomme, France | — |
+ 36 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.